Cargando…

A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus

Recent genome wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here we perform a meta-analysis of three HL GWAS totaling 1,816 cases and 7,877 c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozen, W, Timofeeva, MN, Li, D, Diepstra, A, Hazelett, D, Delahaye-Sourdeix, M, Edlund, CK, Franke, L, Rostgaard, K, Van Den Berg, DJ, Cortessis, VK, Smedby, KE, Glaser, SL, H-J, Westra, Robison, LL, Mack, TM, Ghesquieres, H, Hwang, AE, Nieters, A, de Sanjose, S, Lightfoot, T, Becker, N, Maynadie, M, Foretova, L, Roman, E, Benavente, Y, Rand, KA, Nathwani, BN, Glimelius, B, Staines, A, Boffetta, P, Link, BK, Kiemeney, L, Ansell, SM, Bhatia, S, Strong, LC, Galan, P, Vatten, L, Habermann, TM, Duell, EJ, Lake, A, Veenstra, RN, Visser, L, Liu, Y, Urayama, KY, Montgomery, D, Gaborieau, V, Weiss, LM, Byrnes, G, Lathrop, M, Cocco, P, Best, T, Skol, AD, H-O, Adami, Melbye, M, Cerhan, JR, Gallagher, A, Taylor, GM, Slager, SL, Brennan, P, Coetzee, GA, Conti, DV, Onel, K, Jarrett, RF, Hjalgrim, H, van den Berg, A, McKay, JD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055950/
https://www.ncbi.nlm.nih.gov/pubmed/24920014
http://dx.doi.org/10.1038/ncomms4856
_version_ 1782320756342915072
author Cozen, W
Timofeeva, MN
Li, D
Diepstra, A
Hazelett, D
Delahaye-Sourdeix, M
Edlund, CK
Franke, L
Rostgaard, K
Van Den Berg, DJ
Cortessis, VK
Smedby, KE
Glaser, SL
H-J, Westra
Robison, LL
Mack, TM
Ghesquieres, H
Hwang, AE
Nieters, A
de Sanjose, S
Lightfoot, T
Becker, N
Maynadie, M
Foretova, L
Roman, E
Benavente, Y
Rand, KA
Nathwani, BN
Glimelius, B
Staines, A
Boffetta, P
Link, BK
Kiemeney, L
Ansell, SM
Bhatia, S
Strong, LC
Galan, P
Vatten, L
Habermann, TM
Duell, EJ
Lake, A
Veenstra, RN
Visser, L
Liu, Y
Urayama, KY
Montgomery, D
Gaborieau, V
Weiss, LM
Byrnes, G
Lathrop, M
Cocco, P
Best, T
Skol, AD
H-O, Adami
Melbye, M
Cerhan, JR
Gallagher, A
Taylor, GM
Slager, SL
Brennan, P
Coetzee, GA
Conti, DV
Onel, K
Jarrett, RF
Hjalgrim, H
van den Berg, A
McKay, JD
author_facet Cozen, W
Timofeeva, MN
Li, D
Diepstra, A
Hazelett, D
Delahaye-Sourdeix, M
Edlund, CK
Franke, L
Rostgaard, K
Van Den Berg, DJ
Cortessis, VK
Smedby, KE
Glaser, SL
H-J, Westra
Robison, LL
Mack, TM
Ghesquieres, H
Hwang, AE
Nieters, A
de Sanjose, S
Lightfoot, T
Becker, N
Maynadie, M
Foretova, L
Roman, E
Benavente, Y
Rand, KA
Nathwani, BN
Glimelius, B
Staines, A
Boffetta, P
Link, BK
Kiemeney, L
Ansell, SM
Bhatia, S
Strong, LC
Galan, P
Vatten, L
Habermann, TM
Duell, EJ
Lake, A
Veenstra, RN
Visser, L
Liu, Y
Urayama, KY
Montgomery, D
Gaborieau, V
Weiss, LM
Byrnes, G
Lathrop, M
Cocco, P
Best, T
Skol, AD
H-O, Adami
Melbye, M
Cerhan, JR
Gallagher, A
Taylor, GM
Slager, SL
Brennan, P
Coetzee, GA
Conti, DV
Onel, K
Jarrett, RF
Hjalgrim, H
van den Berg, A
McKay, JD
author_sort Cozen, W
collection PubMed
description Recent genome wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here we perform a meta-analysis of three HL GWAS totaling 1,816 cases and 7,877 controls followed by replication in an independent set of 1,281 cases and 3,218 controls to find novel risk loci. We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio [OR] = 0.81, 95% confidence interval [95% CI] = 0.76–0.86, P(combined) = 3.5 × 10(−10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis. This meta-analysis also notes associations between previously published loci at 2p16.1, 5q31, 6p31.2, 8q24.21 and 10p14 and HL subtypes. We conclude that our data suggest a link between the 19p13.3 locus, including TCF3, and HL risk
format Online
Article
Text
id pubmed-4055950
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-40559502014-12-12 A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus Cozen, W Timofeeva, MN Li, D Diepstra, A Hazelett, D Delahaye-Sourdeix, M Edlund, CK Franke, L Rostgaard, K Van Den Berg, DJ Cortessis, VK Smedby, KE Glaser, SL H-J, Westra Robison, LL Mack, TM Ghesquieres, H Hwang, AE Nieters, A de Sanjose, S Lightfoot, T Becker, N Maynadie, M Foretova, L Roman, E Benavente, Y Rand, KA Nathwani, BN Glimelius, B Staines, A Boffetta, P Link, BK Kiemeney, L Ansell, SM Bhatia, S Strong, LC Galan, P Vatten, L Habermann, TM Duell, EJ Lake, A Veenstra, RN Visser, L Liu, Y Urayama, KY Montgomery, D Gaborieau, V Weiss, LM Byrnes, G Lathrop, M Cocco, P Best, T Skol, AD H-O, Adami Melbye, M Cerhan, JR Gallagher, A Taylor, GM Slager, SL Brennan, P Coetzee, GA Conti, DV Onel, K Jarrett, RF Hjalgrim, H van den Berg, A McKay, JD Nat Commun Article Recent genome wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here we perform a meta-analysis of three HL GWAS totaling 1,816 cases and 7,877 controls followed by replication in an independent set of 1,281 cases and 3,218 controls to find novel risk loci. We identify a novel variant at 19p13.3 associated with HL (rs1860661; odds ratio [OR] = 0.81, 95% confidence interval [95% CI] = 0.76–0.86, P(combined) = 3.5 × 10(−10)), located in intron 2 of TCF3 (also known as E2A), a regulator of B- and T-cell lineage commitment known to be involved in HL pathogenesis. This meta-analysis also notes associations between previously published loci at 2p16.1, 5q31, 6p31.2, 8q24.21 and 10p14 and HL subtypes. We conclude that our data suggest a link between the 19p13.3 locus, including TCF3, and HL risk 2014-06-12 /pmc/articles/PMC4055950/ /pubmed/24920014 http://dx.doi.org/10.1038/ncomms4856 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Cozen, W
Timofeeva, MN
Li, D
Diepstra, A
Hazelett, D
Delahaye-Sourdeix, M
Edlund, CK
Franke, L
Rostgaard, K
Van Den Berg, DJ
Cortessis, VK
Smedby, KE
Glaser, SL
H-J, Westra
Robison, LL
Mack, TM
Ghesquieres, H
Hwang, AE
Nieters, A
de Sanjose, S
Lightfoot, T
Becker, N
Maynadie, M
Foretova, L
Roman, E
Benavente, Y
Rand, KA
Nathwani, BN
Glimelius, B
Staines, A
Boffetta, P
Link, BK
Kiemeney, L
Ansell, SM
Bhatia, S
Strong, LC
Galan, P
Vatten, L
Habermann, TM
Duell, EJ
Lake, A
Veenstra, RN
Visser, L
Liu, Y
Urayama, KY
Montgomery, D
Gaborieau, V
Weiss, LM
Byrnes, G
Lathrop, M
Cocco, P
Best, T
Skol, AD
H-O, Adami
Melbye, M
Cerhan, JR
Gallagher, A
Taylor, GM
Slager, SL
Brennan, P
Coetzee, GA
Conti, DV
Onel, K
Jarrett, RF
Hjalgrim, H
van den Berg, A
McKay, JD
A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus
title A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus
title_full A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus
title_fullStr A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus
title_full_unstemmed A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus
title_short A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus
title_sort meta-analysis of hodgkin lymphoma reveals 19p13.3 tcf3 as a novel susceptibility locus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055950/
https://www.ncbi.nlm.nih.gov/pubmed/24920014
http://dx.doi.org/10.1038/ncomms4856
work_keys_str_mv AT cozenw ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT timofeevamn ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lid ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT diepstraa ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hazelettd ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT delahayesourdeixm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT edlundck ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT frankel ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT rostgaardk ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT vandenbergdj ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT cortessisvk ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT smedbyke ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT glasersl ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hjwestra ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT robisonll ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT macktm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT ghesquieresh ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hwangae ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT nietersa ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT desanjoses ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lightfoott ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT beckern ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT maynadiem ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT foretoval ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT romane ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT benaventey ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT randka ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT nathwanibn ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT glimeliusb ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT stainesa ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT boffettap ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT linkbk ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT kiemeneyl ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT ansellsm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT bhatias ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT stronglc ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT galanp ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT vattenl ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT habermanntm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT duellej ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lakea ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT veenstrarn ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT visserl ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT liuy ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT urayamaky ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT montgomeryd ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT gaborieauv ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT weisslm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT byrnesg ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lathropm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT coccop ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT bestt ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT skolad ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hoadami ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT melbyem ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT cerhanjr ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT gallaghera ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT taylorgm ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT slagersl ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT brennanp ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT coetzeega ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT contidv ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT onelk ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT jarrettrf ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hjalgrimh ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT vandenberga ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT mckayjd ametaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT cozenw metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT timofeevamn metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lid metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT diepstraa metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hazelettd metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT delahayesourdeixm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT edlundck metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT frankel metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT rostgaardk metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT vandenbergdj metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT cortessisvk metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT smedbyke metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT glasersl metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hjwestra metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT robisonll metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT macktm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT ghesquieresh metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hwangae metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT nietersa metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT desanjoses metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lightfoott metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT beckern metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT maynadiem metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT foretoval metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT romane metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT benaventey metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT randka metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT nathwanibn metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT glimeliusb metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT stainesa metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT boffettap metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT linkbk metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT kiemeneyl metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT ansellsm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT bhatias metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT stronglc metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT galanp metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT vattenl metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT habermanntm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT duellej metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lakea metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT veenstrarn metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT visserl metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT liuy metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT urayamaky metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT montgomeryd metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT gaborieauv metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT weisslm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT byrnesg metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT lathropm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT coccop metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT bestt metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT skolad metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hoadami metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT melbyem metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT cerhanjr metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT gallaghera metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT taylorgm metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT slagersl metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT brennanp metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT coetzeega metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT contidv metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT onelk metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT jarrettrf metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT hjalgrimh metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT vandenberga metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus
AT mckayjd metaanalysisofhodgkinlymphomareveals19p133tcf3asanovelsusceptibilitylocus